/IMMVF
IMMVF Stock - Immunovia AB (publ)
Healthcare|Medical - Diagnostics & ResearchOTC
$0.05+0.00%
+$0.00 (+0.00%) • Dec 19
42
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.21
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.10
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.06
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for IMMVF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.05 – $0.05
TARGET (TP)$0.06
STOP LOSS$0.05
RISK/REWARD1:3.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.76
52W High$0.15
52W Low$0.05
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $931,000 | $1.57M | $1.15M | $844,000 | $362,000 |
| Gross Profit | $931,000 | $-5,107,000 | $-3,066,000 | $15.81M | $40.38M |
| Gross Margin | 100.0% | -324.3% | -267.8% | 1873.6% | 11155.2% |
| Operating Income | $-109,411,000 | $-296,460,000 | $-191,150,000 | $-166,628,000 | $-134,343,000 |
| Net Income | $-76,541,000 | $-309,439,000 | $-168,092,000 | $-155,966,000 | $-146,033,000 |
| Net Margin | -8221.4% | -19646.9% | -14680.5% | -18479.4% | -40340.6% |
| EPS | $-0.93 | $-7.95 | $-6.89 | $-6.40 | $-6.35 |
Company Overview
Immunovia AB (publ), a diagnostic company, develops and commercializes blood tests in Sweden and internationally. The company's product includes IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer. It also develops research projects for lung cancer. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
IMMVFBeat Rate
100%
Last 1 quarters
Avg Surprise
+82.2%
EPS vs Estimate
Beats / Misses
1/0
Last 12 quarters
Latest EPS
$-0.00
Q4 2025
EPS Surprise History
Q3 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q4 25
+82.2%
$-0.00vs$-0.00
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 12, 2026 | — | — | — | — |
Q1 2026 | Feb 24, 2026 | — | — | — | — |
Q4 2025 | Nov 26, 2025 | $-0.00 | $-0.00 | +82.2% | ✓ BEAT |
Q2 2025 | May 14, 2025 | — | $-0.02 | — | — |
Q1 2025 | Feb 25, 2025 | — | $0.00 | — | — |
Q4 2024 | Nov 27, 2024 | — | $-0.11 | — | — |
Q3 2024 | Aug 5, 2024 | — | $-0.05 | — | — |
Q2 2024 | Apr 29, 2024 | — | $-0.01 | — | — |
Q1 2024 | Feb 21, 2024 | — | $-0.11 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.08 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.37 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.22 | — | — |
Q1 2023 | Feb 23, 2023 | — | $-0.27 | — | — |
Q4 2022 | Nov 10, 2022 | — | $-0.09 | — | — |
Q3 2022 | Aug 24, 2022 | — | $-0.14 | — | — |
Q2 2022 | Apr 28, 2022 | — | $-0.21 | — | — |
Q1 2022 | Feb 17, 2022 | — | $-0.21 | — | — |
Q4 2021 | Nov 11, 2021 | — | $-0.17 | — | — |
Q3 2021 | Aug 19, 2021 | — | $-0.24 | — | — |
Q2 2021 | Apr 28, 2021 | — | $-0.11 | — | — |
Latest News
Loading news...
Frequently Asked Questions about IMMVF
What is IMMVF's current stock price?
Immunovia AB (publ) (IMMVF) is currently trading at $0.05 per share. The stock has moved +0.00% today.
What is the analyst price target for IMMVF?
No analyst price targets are currently available for this stock.
What sector is Immunovia AB (publ) in?
Immunovia AB (publ) operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the OTC exchange.
What is IMMVF's market cap?
Immunovia AB (publ) has a market capitalization of $0.02 billion, making it a small-cap company.
Does IMMVF pay dividends?
No, Immunovia AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorANPCY
CelLBxHealth plc
$0.07
Mkt Cap: $0.0B
ASAPF
Aurora Spine Corporation
$0.20
Mkt Cap: $0.0B
CLCS
Cell Source, Inc.
$0.50
Mkt Cap: $0.0B
MBGNF
Many Bright Ideas Technologies Inc.
$0.01
Mkt Cap: $0.0B
OPGN
OpGen, Inc.
$12.79
Mkt Cap: $0.1B
PPCB
Propanc Biopharma, Inc.
$0.71
Mkt Cap: $0.0B
RYAHF
RYAH Group, Inc.
$0.01
Mkt Cap: $0.0B
SYGGF
Synairgen plc
$0.00
Mkt Cap: $0.0B
UEEC
United Health Products, Inc.
$0.06
Mkt Cap: $0.0B
ZHCLF
Zenith Capital Corp.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to IMMVF for comparison